loading page

Transcarotid Transcatheter Aortic Valve Implantation with a Novel Balloon Expandable Myval® THV under the Local Anesthesia
  • +3
  • Hüseyin Ayhan,
  • Bilge Duran Karaduman,
  • Telat Keles,
  • Emrah Uguz,
  • Emre Boysan,
  • Engin Bozkurt
Hüseyin Ayhan
Atılım University Faculty of Medicine Department of Cardiology Medicana International Ankara Hospital Street Çankaya Postal code 068510 City/Country Ankara/Turkey

Corresponding Author:[email protected]

Author Profile
Bilge Duran Karaduman
Atılım University Faculty of Medicine Department of Cardiology Medicana International Ankara Hospital Street Çankaya Postal code 068510 City/Country Ankara/Turkey
Author Profile
Telat Keles
Ankara Yildirim Beyazit Universitesi Tip Fakultesi
Author Profile
Emrah Uguz
Ankara Yildirim Beyazit Universitesi Tip Fakultesi
Author Profile
Emre Boysan
Medicana International Ankara Hastanesi
Author Profile
Engin Bozkurt
Medicana International Ankara Hastanesi
Author Profile

Abstract

In patients unsuitable for transfemoral transcatheter aortic valve implantation (TF-TAVI) due to peripheral artery disease, another route such as trans-subclavian-axillary or transcarotid is a becoming alternative. The novel Myval transcatheter heart valve system technology is a second-generation balloon-expandable valve described by design innovations that promote accurate positioning of the valve and warrant accurate orthotopic valve deployment. To our knowledge, this is the first case report in the literature of successful transcarotid TAVI via the novel balloon-expandable Myval THV system under the local anesthesia for heavily calcific and stenotic abdominal aorta and subclavian arteries.